- Home
- KURA vs HSII Comparison
KURA vs HSII Comparison
Compare KURA & HSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- HSII
- Stock Information
- Founded
- KURA 2014
- HSII 1953
- Country
- KURA United States
- HSII United States
- Employees
- KURA N/A
- HSII N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- HSII Diversified Commercial Services
- Sector
- KURA Health Care
- HSII Consumer Discretionary
- Exchange
- KURA Nasdaq
- HSII Nasdaq
- Market Cap
- KURA 793.2M
- HSII 904.3M
- IPO Year
- KURA N/A
- HSII 1999
- Fundamental
- Price
- KURA $7.26
- HSII $46.09
- Analyst Decision
- KURA Strong Buy
- HSII Buy
- Analyst Count
- KURA 11
- HSII 2
- Target Price
- KURA $27.89
- HSII $46.00
- AVG Volume (30 Days)
- KURA 1.7M
- HSII 156.8K
- Earning Date
- KURA 02-25-2025
- HSII 02-24-2025
- Dividend Yield
- KURA N/A
- HSII 1.30%
- EPS Growth
- KURA N/A
- HSII N/A
- EPS
- KURA N/A
- HSII 1.83
- Revenue
- KURA N/A
- HSII $1,075,544,000.00
- Revenue This Year
- KURA N/A
- HSII $7.90
- Revenue Next Year
- KURA $233.30
- HSII $3.07
- P/E Ratio
- KURA N/A
- HSII $25.23
- Revenue Growth
- KURA N/A
- HSII 6.55
- 52 Week Low
- KURA $6.98
- HSII $27.07
- 52 Week High
- KURA $24.17
- HSII $49.02
- Technical
- Relative Strength Index (RSI)
- KURA 19.21
- HSII 62.14
- Support Level
- KURA $7.02
- HSII $45.67
- Resistance Level
- KURA $7.66
- HSII $46.48
- Average True Range (ATR)
- KURA 0.34
- HSII 0.98
- MACD
- KURA 0.07
- HSII 0.22
- Stochastic Oscillator
- KURA 13.76
- HSII 89.20
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
About HSII Heidrick & Struggles International Inc.
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments includes the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.